The expression of the macrophage scavenger receptor 1 (MSR1) was suggested to label a subset of anti-tumor TAMs, being significantly correlated with the inhibition of tumor progression, lower clinical stage, recurrence-free survival, and good prognosis in prostate cancer patients [64]. The gene discussed is MSR1; the disease is neoplasm.